Financhill
Back

Takeda Pharmaceutical 10K Form

Sell
18

TAK
Takeda Pharmaceutical

Last Price:
$14.10
Seasonality Move:
-1.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TAK News And Ratings

See the #1 stock for the next 7 days that we like better than TAK

TAK Financial Statistics

Sales & Book Value

Annual Sales: $30.1B
Cash Flow: $854.8M
Price / Cash Flow: 10.21
Annual Sales: $14.73
Price / Book: 0.95

Profitability

EPS (TTM): 0.21820
Net Income (TTM): $710.2M
Gross Margin: $19.7B
Return on Equity: 1.49%
Return on Assets: 0.72%

Takeda Pharmaceutical Earnings Forecast

Key Takeda Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 26 years for TAK is 65.51%.
  • The Selling, General & Administrative Expenses for TAK have been equal to 24.11% of Gross Profit Margin.
  • The Research & Development expenses have been 15.94% of Revenue.
  • The Interest Expense is 194.63% of Operating Income.
  • The Net Earning history of TAK is 2.36% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 15 years.

Takeda Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TAK
CUSIP: 874060
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.65
Current Ratio: 1.01
Quick Ratio: 0.45

Price-to-Earnings

Trailing P/E Ratio: 63.94
Forward P/E Ratio: 0

TAK Technical Analysis vs Fundamental Analysis

Sell
18
Takeda Pharmaceutical (TAK) is a Sell

Is Takeda Pharmaceutical a Buy or a Sell?